Mettler Toledo Introduces Mechanical Analyzer
The Excellence Dynamic Mechanical Analyzer DMA 1, introduced by Mettler Toledo offers six different deformation modes to gauge materials performance.

Bruker Introduces Mass Spectrometers, NMR Modules
At Pittcon 2013, Bruker introduced a range of instruments and software updates including two LC-triple quadrupole (LC-TQ) mass spectrometers.

Rigaku Raman Upgrades Handheld Analyzer
Rigaku Raman Technologies announced an updated version of the FirstGuard handheld Raman analyzer at Pittcon 2013.

AstraZeneca Announces an Additional 2300 Layoffs
AstraZeneca announced further downsizing in response to an expected period of declining revenues in the face of patent expirations. The company will eliminate 2300 positions in sales and general administration.

IPEC Releases Revised Excipient Information Package Guidance
The 2013 Excipient Information Package (EIP) User Guide is now available for free download from the International Pharmaceutical Excipients Council (IPEC)-Americas.

Advertisement: Tablet manufacturing problems? By partnering with Long Island University, Natoli Engineering has developed the Natoli Engineering Institute for Industrial Pharmacy Development and Research. Our mission is to provide customers with unique product solutions to their specific issues based on a combination of science and experience. Learn More!

Shire to Acquire SARcode for $160 Million
Shire has announced plans to acquire dry eye specialist SARcode Bioscience with the aim of expanding its ophthalmics portfolio. Under the terms of the agreement, Shire will pay $160 million upfront and SARcode shareholders will receive additional undisclosed payments upon achievement of certain clinical, regulatory and/or commercial milestones.

FDA Investigates Med Prep Consulting for Contaminated Intravenous Solution
The New Jersey-licensed specialty pharmacy recalls magnesium sulfate products and halts all production operations.

Advertisement: A Pragmatic Application of QbD: Turning Theory into Tangible Success Live Webcast: Thursday, May 2, 2013 at 11:00 am EDT. Register Free at http://www.pharmtech.com/pragmatic

• FDA has approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
• Gilead Sciences has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion on the company’s marketing authorization application for the once-daily, single tablet regimen Stribild for the treatment of HIV-1 infection.
• Recipharm’s solid-dose facility located in Fontaine, France, has been approved for supply of manufactured products to Japan’s pharmaceuticals market following a recent inspection by the PMDA, the Japanese drug agency.
• Read More